CELLYAN BIOTECHNOLOGY CO-A
HKPD · NASDAQ
Updated at 2026-10-13 15:23:11
- Today's High
- $0.11
- Today’s Low
- $0.10
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.11
- Previous Close
- $0.10
- Volume
- 241.15K
- Market Cap
- $4.49M
- P/E Ratio
- --
- EPS
- --
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Logistics & Transportation
- Sub-industry
- MEDICAL DISTRIBUTION
- Headquarters
- WELL TOWN INDUSTRIAL BUILDING, YAU TONG, HONG KONG, 999077
- Country
- HK
- Listing Date
- 2025-01-15
- Fiscal Year End
- March
- Shares Outstanding
- 23.5M
- CIK
- 0002007702
- Website
- www.9zt.hk
Hong Kong Pharma Digital Technology Holdings Limited is a pioneering entity in the biotechnology and digital healthcare sectors, focused on enhancing patient outcomes through innovative pharmaceutical services. By harnessing cutting-edge digital technologies and sophisticated data analytics, the company optimizes drug development and boosts operational efficiencies, positioning itself as a key player in the dynamic healthcare landscape. With a commitment to health technology advancement and strategic collaborations, Hong Kong Pharma is well-equipped to meet the evolving needs of both domestic and international markets while propelling innovation within its extensive service offerings.
Financial Metrics
Revenue
2026-06-30
$6.29M
2025-12-31
$7.13M
2025-06-30
$4.61M
2025-03-31
$9.22M
Operating Expenses
2026-06-30
$1.68M
2025-12-31
$696.44K
2025-06-30
$702.27K
2025-03-31
$1.4M
Net Income
2026-06-30
-$1.28M
2025-12-31
$153.73K
2025-06-30
-$427.8K
2025-03-31
-$855.61K
Net Profit Margin
2026-06-30
-20.48%
2025-12-31
2.15%
2025-06-30
-9.27%
2025-03-31
-9.27%
Earnings Per Share
2026-06-30
--
2025-12-31
--
2025-06-30
$-0.08
2025-03-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$988.9K
2025-12-31
$258.84K
2025-06-30
-$396.66K
2025-03-31
-$203.6K
Effective Tax Rate
2026-06-30
0.8%
2025-12-31
10.51%
2025-06-30
-9.24%
2025-03-31
-9.24%
| Item | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | $6.29M | $7.13M | $4.61M | $9.22M |
| Operating Expenses | $1.68M | $696.44K | $702.27K | $1.4M |
| Net Income | -$1.28M | $153.73K | -$427.8K | -$855.61K |
| Net Profit Margin | -20.48% | 2.15% | -9.27% | -9.27% |
| Earnings Per Share | -- | -- | $-0.08 | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$988.9K | $258.84K | -$396.66K | -$203.6K |
| Effective Tax Rate | 0.8% | 10.51% | -9.24% | -9.24% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.